F508del-CFTR is not corrected by thymosin α1.

Plain Language Summary

This article presents a scientific correspondence arguing that thymosin alpha-1 does not correct the F508del mutation in the CFTR protein responsible for cystic fibrosis. The finding challenges earlier claims about the peptide's potential as a single-molecule therapy for CF.